Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Aggressive Metaplastic Carcinoma of the Breast with Osteoclastic Giant Cells.

Khong K, Zhang Y, Tomic M, Lindfors K, Aminololama-Shakeri S.

J Radiol Case Rep. 2015 Sep 30;9(9):11-9. doi: 10.3941/jrcr.v9i9.2357. eCollection 2015 Sep.

2.

Metaplastic breast cancer: a comparison between the most common histologies with poor immunohistochemistry factors.

Barquet-Muñoz SA, Villarreal-Colin SP, Herrera-Montalvo LA, Soto-Reyes E, Pérez-Plasencia C, Coronel-Martínez J, Pérez-Montiel D, Vázquez-Romo R, Cantú de León D.

BMC Cancer. 2015 Feb 20;15:75. doi: 10.1186/s12885-015-1079-2.

3.

Mammary carcinoma with osteoclast-like giant cells: a case report.

Albawardi AS, Awwad AA, Almarzooqi SS.

Int J Clin Exp Pathol. 2014 Dec 1;7(12):9038-43. eCollection 2014.

4.

Mixed epithelial and mesenchymal metaplastic carcinoma (carcinosarcoma) of the breast: a case report.

Kang Y, Kang S, Li Q, Zheng X.

Eur J Med Res. 2014 Mar 13;19:14. doi: 10.1186/2047-783X-19-14.

5.

Clinicopathologic features of triple negative breast cancers: an experience from Pakistan.

Hashmi AA, Edhi MM, Naqvi H, Faridi N, Khurshid A, Khan M.

Diagn Pathol. 2014 Feb 28;9:43. doi: 10.1186/1746-1596-9-43.

6.

Squamous cell carcinoma with apocrine features of the breast: A case report.

Naito Y, Yamaguchi R, Tanaka M, Saruwatari A, Torii Y, Tsukamoto T, Nishida N, Higaki K.

Oncol Lett. 2014 Mar;7(3):647-650. Epub 2014 Jan 15.

7.

Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies.

Schwartz TL, Mogal H, Papageorgiou C, Veerapong J, Hsueh EC.

Exp Hematol Oncol. 2013 Nov 14;2(1):31. doi: 10.1186/2162-3619-2-31.

8.

Osteoclastic giant cell rich metaplastic carcinoma in malignant phylloides: A rare entity.

Momin YA, Bharambe BM, Ansari SA, Ghodke BA.

South Asian J Cancer. 2012 Oct;1(2):93-5. doi: 10.4103/2278-330X.103724. No abstract available.

9.

Treatment options for metaplastic breast cancer.

Shah DR, Tseng WH, Martinez SR.

ISRN Oncol. 2012;2012:706162. doi: 10.5402/2012/706162. Epub 2012 Jun 21.

10.

Primary squamous cell carcinoma of breast with ipsilateral axillary lymph node metastasis: An unusual case.

Mitra B, Pal M, Debnath S, Paul B, Saha TN, Maiti A.

Int J Surg Case Rep. 2011;2(7):194-7. doi: 10.1016/j.ijscr.2011.06.006. Epub 2011 Jun 25.

11.

Multifocal invasive ductal breast cancer with osteoclast-like giant cells: a case report.

Richter G, Uleer C, Noesselt T.

J Med Case Rep. 2011 Feb 27;5:85. doi: 10.1186/1752-1947-5-85.

12.

Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers.

Lester TR, Hunt KK, Nayeemuddin KM, Bassett RL Jr, Gonzalez-Angulo AM, Feig BW, Huo L, Rourke LL, Davis WG, Valero V, Gilcrease MZ.

Breast Cancer Res Treat. 2012 Jan;131(1):41-8. doi: 10.1007/s10549-011-1393-6. Epub 2011 Feb 18.

13.

Challenges to diagnose metaplastic carcinoma of the breast through cytologic methods: an eight-case series.

Lale S, Kure K, Lingamfelter D.

Diagn Pathol. 2011 Jan 18;6:7. doi: 10.1186/1746-1596-6-7.

14.

Clinicopathologic features and outcomes of metaplastic breast carcinoma: comparison with invasive ductal carcinoma of the breast.

Park HS, Park S, Kim JH, Lee JH, Choi SY, Park BW, Lee KS.

Yonsei Med J. 2010 Nov;51(6):864-9. doi: 10.3349/ymj.2010.51.6.864.

15.

Metaplastic breast cancer: to radiate or not to radiate?

Tseng WH, Martinez SR.

Ann Surg Oncol. 2011 Jan;18(1):94-103. doi: 10.1245/s10434-010-1198-6. Epub 2010 Jun 29.

16.

Fine-needle aspiration cytology of metaplastic carcinoma of the breast.

Lui PC, Tse GM, Tan PH, Jayaram G, Putti TC, Chaiwun B, Chan NH, Lau PP, Mak KL, Khin AT.

J Clin Pathol. 2007 May;60(5):529-33. Epub 2006 Jun 23.

17.

Metaplastic carcinoma of the breast: a clinicopathological review.

Tse GM, Tan PH, Putti TC, Lui PC, Chaiwun B, Law BK.

J Clin Pathol. 2006 Oct;59(10):1079-83. Epub 2006 Feb 7.

18.

Frequent overexpression of epidermal growth factor receptor (EGFR) in mammary high grade ductal carcinomas with myoepithelial differentiation.

Shien T, Tashiro T, Omatsu M, Masuda T, Furuta K, Sato N, Akashi-Tanaka S, Uehara M, Iwamoto E, Kinoshita T, Fukutomi T, Tsuda H, Hasegawa T.

J Clin Pathol. 2005 Dec;58(12):1299-304.

19.

Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis.

Reis-Filho JS, Milanezi F, Carvalho S, Simpson PT, Steele D, Savage K, Lambros MB, Pereira EM, Nesland JM, Lakhani SR, Schmitt FC.

Breast Cancer Res. 2005;7(6):R1028-35. Epub 2005 Oct 25.

Items per page

Supplemental Content

Write to the Help Desk